Cargando…
Sumoylation-independent activation of Calcineurin-NFAT-signaling via SUMO2 mediates cardiomyocyte hypertrophy
The objective of this study was to identify unknown modulators of Calcineurin (Cn)-NFAT signaling. Measurement of NFAT reporter driven luciferase activity was therefore utilized to screen a human cardiac cDNA-library (~10(7) primary clones) in C2C12 cells through serial dilutions until single clones...
Autores principales: | Bernt, Alexander, Rangrez, Ashraf Y., Eden, Matthias, Jungmann, Andreas, Katz, Sylvia, Rohr, Claudia, Müller, Oliver J., Katus, Hugo A., Sossalla, Samuel T., Williams, Tatjana, Ritter, Oliver, Frank, Derk, Frey, Norbert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073337/ https://www.ncbi.nlm.nih.gov/pubmed/27767176 http://dx.doi.org/10.1038/srep35758 |
Ejemplares similares
-
Dysbindin is a potent inducer of RhoA–SRF-mediated cardiomyocyte hypertrophy
por: Rangrez, Ashraf Yusuf, et al.
Publicado: (2013) -
The E3 ubiquitin ligase HectD3 attenuates cardiac hypertrophy and inflammation in mice
por: Rangrez, Ashraf Yusuf, et al.
Publicado: (2020) -
Betulinic Acid Protects DOX-Triggered Cardiomyocyte Hypertrophy Response through the GATA-4/Calcineurin/NFAT Pathway
por: Yoon, Jung Joo, et al.
Publicado: (2020) -
Cardiomyocyte-specific overexpression of syndecan-4 in mice results in activation of calcineurin-NFAT signalling and exacerbated cardiac hypertrophy
por: Lunde, Ida G., et al.
Publicado: (2022) -
AAV-mediated expression of NFAT decoy oligonucleotides protects from cardiac hypertrophy and heart failure
por: Remes, Anca, et al.
Publicado: (2021)